Live Breaking News & Updates on Haukeland universitetssykehus
Stay updated with breaking news from Haukeland universitetssykehus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The addition of bemcentinib to the standard-of-care therapies of pembrolizumab or dabrafenib plus trametinib was well tolerated in patients with metastatic melanoma; however, it did not lead to improvements in overall response rate, progression-free survival, or overall survival vs SOC alone.